Murepavadin [T1L,W2S,I3Y,DAB10tBuGly]

General Information


DRACP ID  DRACP04146

Peptide Name   Murepavadin [T1L,W2S,I3Y,DAB10tBuGly]

Sequence  LSYXXxXWXXASpP

Sequence Length  14

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C40H40N8O4

Absent amino acids  CDEFGHIKMNQRTV

Common amino acids  X

Mass  147885

Pl  6.09

Basic residues  0

Acidic residues  0

Hydrophobic residues  3

Net charge  0

Boman Index  212

Hydrophobicity  1.43

Aliphatic Index  35

Half Life 
  /

Extinction Coefficient cystines  6990

Absorbance 280nm  537.69

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31645764

Title  Chimeric peptidomimetic antibiotics against Gram-negative bacteria

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17725

DRACP is developed by Dr.Zheng's team.